If you’re a fan of the hit TV show Shark Tank, you’ve probably come across the intriguing term “unicorn” companies. Indeed, these fantastical entities are not only confined to the realm of imagination. In the field of finance, they are very real and coveted by venture investors looking for promising enterprises and valuations. The term “unicorn” in these contexts refers to privately owned companies whose valuations exceed the golden figure of $1 billion, and healthcare stocks are among the elite.
Rather than looking for the next unicorn startup, we wanted instead to look at established companies that possessed “unicorn” qualities. Today, we’re highlighting companies that have been undervalued and have amazing growth prospects. There are hundreds of small pharmaceutical and biotech companies vying for attention, creating innovative products and growing at explosive speeds. In this article, we’ll spotlight seven healthcare stocks with “unicorn”-like metrics that investors should look into.
This post appeared first on InvestorPlace.